IJCRR - 8(16), August, 2016
A STUDY OF SHORT-TERM OUTCOME OF ACUTE CORONARY SYNDROME PATIENTS WITH SPECIAL REFERENCE TO SERUM URIC ACID AT PRESENTATION
Author: Kapildev Mondal, Soumabrota Dutta
Background: Acute coronary syndrome is very common course of death worldwide. It is the most common life Threatening cardiological disease. Assessment of prognosis of acute coronary syndrome patient with respect of Uric acid level as a risk factor to prevent mortality and morbidity have great impact on public health.
Aim of the study: Very few Literatures are available regarding this. Our objective is to find out the Effect of Serum Uric acid level on short term outcome of acute coronary syndrome patient.
Materials and Methods: We did retrospective study in general medicine department of SSKM HOSPITAL; Kolkata, with acute coronary syndrome patients on 2009-2010.
Our study included 100 patients of acute coronary syndrome of various severity. We also proposed to do a detailed laboratory investigation including serum uric acid level in every patient. We did Detailed Clinical Examination and Relevant laboratory investigation. We collected Data according to Hospital regulation after approval by Hospital authorities. Then we analyzed data with help of statistical method BY using software.
Results: In our study serum uric acid levels correlate with severity of cardiac failure. There was statistically significant correlation found between serum uric had higher levels of uric acid as compared to patients of class l and ll.
Discussion: Out of 100 patients, six expired during 7 day follow up. Patients who had myocardial infarction in past have higher serum uric acid levels and are in higher Killip class. Combination of Killip class and serum uric acid level after acute myocardial infarction is a good predictor of mortality after ami.
Conclusion: Hyperurecemia is found to be associated with less chance of good outcome of acute coronary syndrome patients.
Keywords: Hyperurecemia, Investigation, Arthritis
Kapildev Mondal, Soumabrota Dutta. A STUDY OF SHORT-TERM OUTCOME OF ACUTE CORONARY SYNDROME PATIENTS WITH SPECIAL REFERENCE TO SERUM URIC ACID AT PRESENTATION International Journal of Current Research and Review. 8(16), August, 14-20
1. Alderman M, Aiyer KJ. Uric acid: role in cardiovascular disease and effects of losartan. Curr Med Res Opin 2004;20:369-79.
2. Kroll K, Bukowski TR, Schwartz LM, Knoepfler D, Bassingthwaighte JB. Capillary endothelial transport of uric acid in guinea pig heart. Am J Physiol 1992, 262:H420-31.
3. Castelli P, Condemi AM, Brambillasca C, et al. Improvement of cardiac function by allopurinol in patients undergoing cardiac surgery. J Cardiovasc Pharmacol 1995;25:119–25.
4. Kogure K, Ishizaki M, Nemoto M, et al. Evaluation of serum uric acid changes in different forms of hepatic vascular inflow occlusion in human liver surgeries. Life Sci 1999;64:305–13.
5. Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and haemodynamic staging. Circulation 2003;22:1991–97.
6. Ochiai ME, Barretto AC, Oliveira MT, et al. Uric acid renal excretion and renal in sufficiency in decompensated severe heart failure. Eur J Heart Fail 2005;7:468–74.
7. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;21:1685–95.
8. Fest a A, Haffner SM. Inflammat ion and cardiovascular disease in patients with diabetes: lessons from the Diabetes Control and Complications Trial . Circulation 2005; 11 :2414–15.
9. Kojima S, Sakamoto T, Ishihara M, et al. Prognostic usefulness of serum uric acid after acute myocardial infarction (Japanese Acute coronary Syndrome Study) . AmJ Cardiol 2005 ; 96 :489-95.
10. Bickel C, Rupprecht HJ, Blankenberg S, et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002;89:12-7.
11. Johnson RJ, Rodriguez-Iturbe B, Kang DH, et al. A unifying pathway foressential hypertension. Am J Hypertens 2005;18:431-40.
12. Tuomilheto J, Zimmet P, Evawolf. Plasma Uric acid level and its association with Diabetes Mellitus and some Biologic Parameters in a Biracial Population of FIJI Am J Epidemiol 1988;127:32136.
13. Safi AJ, Mahmood R, Khan MA, Haq A. Association of serum Uric Acid with type II diabetes mellitus. J Postgrad Med Inst 2004;18:59-63.
14. Cicoira M, Zanolla L, Rossi A, et al. Elevated Serum Uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy . Am Heart J 2002;143:1107-11.
15. Olexa P, Olexova M, Gonsorcik J, et al. Uric acid a marker for systemic inflammatory response in patients with congestive heart failure? Wien KIin Wochenschr 2002;28:211–15.
16. Harison’s Internal medicine 17th edition(Chapter 220,221,238,239).
17. Braunwald’s Heart Disease 8th edition(Chapter 50,51). 18. Davidson’s principle and practice of medicine 21th edition (chapter 18).
19. Hare JM, Johnson RJ. Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology. Circulation 2003;107: 1951-3.
20. Mercuro G, Vitale C, Cerquetani E, et al. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 2004;94:932-5.
21. War d HJ . Uric acid as an independent risk factor in the treatment of hypertension. Lancet 1998;352:670-1.